Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
14.52
Dollar change
+0.23
Percentage change
1.61
%
IndexRUT P/E- EPS (ttm)-4.15 Insider Own4.05% Shs Outstand37.16M Perf Week3.27%
Market Cap543.19M Forward P/E- EPS next Y-0.81 Insider Trans0.00% Shs Float35.89M Perf Month10.84%
Income-151.40M PEG- EPS next Q-0.49 Inst Own96.20% Short Float10.33% Perf Quarter4.99%
Sales746.64M P/S0.73 EPS this Y64.32% Inst Trans-0.56% Short Ratio8.02 Perf Half Y15.15%
Book/sh16.11 P/B0.90 EPS next Y44.90% ROA-21.88% Short Interest3.71M Perf Year-7.28%
Cash/sh1.01 P/C14.39 EPS next 5Y9.40% ROE-32.36% 52W Range9.57 - 21.60 Perf YTD7.72%
Dividend Est.- P/FCF- EPS past 5Y- ROI-20.81% 52W High-32.78% Beta1.04
Dividend TTM- Quick Ratio1.20 Sales past 5Y13.08% Gross Margin62.80% 52W Low51.64% ATR (14)0.54
Dividend Ex-Date- Current Ratio2.54 EPS Y/Y TTM-321.91% Oper. Margin-18.99% RSI (14)58.71 Volatility3.80% 4.15%
Employees1634 Debt/Eq0.22 Sales Y/Y TTM62.06% Profit Margin-20.28% Recom2.50 Target Price18.47
Option/ShortYes / Yes LT Debt/Eq0.22 EPS Q/Q-70.05% Payout- Rel Volume0.54 Prev Close14.29
Sales Surprise0.06% EPS Surprise-1080.07% Sales Q/Q63.97% EarningsMar 05 AMC Avg Volume462.26K Price14.52
SMA205.60% SMA504.66% SMA200-2.06% Trades Volume248,060 Change1.61%
Date Action Analyst Rating Change Price Target Change
Oct-20-23Initiated ROTH MKM Neutral $12
Sep-12-23Downgrade Stifel Buy → Hold
Sep-12-23Downgrade BTIG Research Buy → Neutral
Jul-19-23Resumed BTIG Research Buy $27
Mar-04-22Upgrade Stifel Hold → Buy $41 → $45
Oct-20-20Initiated Stifel Hold $39
Oct-29-19Downgrade Cantor Fitzgerald Overweight → Neutral $71 → $48
Jun-01-18Initiated Cantor Fitzgerald Overweight
Jun-21-17Initiated BTIG Research Buy $52
Jun-14-17Initiated Ladenburg Thalmann Buy $53.25
Mar-18-24 07:00AM
Mar-12-24 11:01AM
Mar-07-24 01:40PM
09:53AM
Mar-06-24 08:21AM
10:52PM Loading…
Mar-05-24 10:52PM
04:42PM
04:03PM
Feb-29-24 07:00AM
Feb-21-24 07:00AM
Jan-18-24 07:00AM
Jan-16-24 07:00AM
Jan-09-24 08:00AM
Jan-08-24 07:00AM
Dec-27-23 08:45AM
07:00AM Loading…
Dec-21-23 07:00AM
Dec-12-23 07:00AM
Dec-11-23 09:55AM
Dec-01-23 06:16PM
Nov-29-23 12:21PM
07:00AM
Nov-28-23 11:30AM
07:00AM
Nov-27-23 10:48AM
Nov-24-23 12:28PM
Nov-23-23 09:55AM
Nov-21-23 06:30PM
Nov-13-23 09:00AM
Nov-09-23 01:43PM
Nov-08-23 05:36PM
04:07PM Loading…
04:07PM
09:00AM
Nov-07-23 03:59PM
Nov-06-23 07:00AM
Nov-02-23 10:00AM
Nov-01-23 10:01AM
Oct-31-23 01:48PM
Oct-29-23 09:00PM
Oct-23-23 09:00PM
03:54PM
Oct-18-23 09:00PM
07:00AM
Oct-17-23 08:33AM
Oct-13-23 09:00PM
08:40PM
08:23AM
Oct-12-23 09:10AM
07:00AM
Oct-09-23 05:25PM
01:48PM
Oct-08-23 09:00PM
Oct-06-23 09:13AM
Oct-02-23 09:00PM
Sep-27-23 09:00PM
Sep-21-23 09:22AM
Sep-20-23 07:00AM
Sep-15-23 01:03PM
Sep-12-23 02:41PM
07:03AM
Sep-01-23 09:55AM
Aug-31-23 08:00AM
Aug-29-23 09:40AM
Aug-28-23 07:00AM
Aug-23-23 07:00AM
Aug-08-23 07:15PM
06:17PM
04:08PM
Jul-25-23 07:00AM
Jun-28-23 07:00AM
Jun-21-23 08:00PM
Jun-20-23 04:01PM
11:39AM
Jun-19-23 07:00AM
Jun-01-23 07:00AM
May-09-23 05:15PM
04:10PM
04:01PM
May-04-23 07:00AM
Apr-26-23 08:00PM
04:01PM
Apr-25-23 07:00AM
Apr-06-23 09:05AM
Apr-04-23 08:43AM
Apr-03-23 08:53AM
Mar-10-23 08:26AM
Mar-08-23 10:08AM
07:00AM
Mar-07-23 08:03AM
07:00AM
Mar-06-23 04:01PM
Mar-03-23 07:00AM
Feb-22-23 04:05PM
Feb-21-23 04:05PM
Jan-26-23 07:00AM
Jan-14-23 03:14PM
Jan-09-23 07:00AM
Jan-04-23 04:01PM
Dec-22-22 10:15AM
07:00AM
Dec-20-22 08:43AM
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kenny Kevin J.President of Global SpineJan 08 '24Option Exercise0.005,9590147,321Jan 10 04:55 PM
Hinrichs James F.DirectorSep 14 '23Buy13.477,500101,02586,153Sep 14 05:15 PM
Kenny Kevin J.President of Global SpineMay 26 '23Sale19.003,87673,644142,431May 26 05:50 PM
Kenny Kevin J.President of Global SpineMay 24 '23Sale19.004,36782,973146,307May 26 05:50 PM